NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SamanTree Medical

SamanTree Medical

Private
LausanneHealthcare & Life Scienceshttps://www.samantree.com/

Last Round

Debt

Jan 27, 2026

Total Funding Raised

$60.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SamanTree Medical is a medical device company that develops and commercializes the Histolog® Scanner, a digital microscopy device for real-time imaging of excised tissue during oncologic surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

confocal microscopyintraoperative imagingsurgical margin assessmentdigital pathologymedical imaging deviceoncologic surgeryclinical decision supportpathology lab equipmentreal-time histologyAI-augmented pathologyfrozen section alternativesurgical guidancemedical device consumablesimage analysis software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SamanTree Medical Comps

Public and private peers based on sector, stage, and business model.

SamanTree Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SamanTree Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJan 27, 2026
Series B ExtensionApr 8, 2025
Series BJul 16, 2024
Series AMay 7, 2019
GrantSep 1, 2018
Debt
Jun 27, 2018

Key People

Founding team and executive leadership

Olivier Delporte

Chief Executive Officer

Executive Team

Bertrand Grimmonpré

Chief Financial Officer

Executive Team

SamanTree Medical Investors

Notable investors and investment history

SamanTree Medical investors
InvestorRounds
European Innovation CouncilGrant
Foundation for Technological InnovationDebt
Sioux Tech FundSeries A
NoshaqSeries B Extension, Series B
Brabantse Ontwikkelings MaatschappijSeries B Extension, Series B
Wallonie EntreprendreSeries B
Turenne GroupeSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 27, 2026

    $24M debt round completed.

  • Jan 27, 2026

    Secured €20 million from the European Investment Bank for microscopy scanner development.

SamanTree Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SamanTree Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SamanTree Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersLausanne
Employee Range60
Year Founded2014
Last FundingJan 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.